Autonomous AI screens for cognitive decline using routine clinical notes
An autonomous AI system capable of screening for cognitive decline using routine clinical documentation has been developed by researchers at the Boston-based Mass General Brigham. The system, which requires no human intervention or prompting after deployment, achieved 98% specificity in real-world validation testing: that is, the rate at which it reduces false positives. Corresponding author on the study Hossein Estiri said: “This AI system includes five specialised agents that critique each other and refine their reasoning, just like clinicians would in a case conference.” Cognitive impairment remains significantly underdiagnosed in routine clinical care, and traditional screening tools and cognitive tests are highly resource-intensive to administer and difficult for patients to access…